Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B
Mauro Viganò(Ospedale San Giuseppe), Massimo Colombo(University of Milan), Benedetta Donati(University of Milan), Paola Dongiovanni(Ospedale Maggiore), Luca Valenti(University of Verona), Roberta D’Ambrosio(University of Southern California), Silvia Fargion(Institute of Clinical and Experimental Medicine), F. Facchetti(University of Milan), Benedetta Maria Motta(Eurac Research), Pietro Lampertico(University of Milan), Solange Romagnoli(University of Milan)
Cited by 77
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789